August Global Partners, a leading independent healthcare and technology investor in Asia, has successfully closed its second fund, the AGP Healthcare Fund (AGPHC), at $150m. This achievement surpasses initial fundraising targets despite ongoing challenges in the global private equity and venture capital sectors. The firm, known for its role in shaping Singapore’s biomedical sector, has now expanded its assets under management to $350m.
The AGPHC fund has attracted commitments from a diverse range of financial, institutional, and strategic limited partners across Asia, Europe, and North America. This success builds on the performance of the AGP Continuation Growth Fund (AGPCG), which supports local champions in healthcare and deep technology sectors. AGPCG has consistently delivered strong returns, evidenced by meaningful Distribution to Paid-In Capital (DPI) to its investors.
AGP’s investment strategy is anchored by the theme “Living Better, Ageing Better,” targeting high-growth opportunities in healthtech, advanced manufacturing, digital health, and precision medicine. The fund has already deployed capital into a portfolio of high-impact growth companies, demonstrating early value creation for its investors.
Chair and Founding Partner Chu Swee Yeok highlighted AGP’s “deep sector expertise, trusted global networks, and commercial agility” as key differentiators. Founding Partner Basil Lui noted the convergence of medical technology, digital health, and AI as presenting unprecedented opportunities for innovation and growth, particularly in addressing the needs of ageing populations and chronic disease management.
AGP remains committed to partnering with visionary founders to drive breakthroughs in next-generation care delivery, from genomics and oncology to AI-powered wearables and medtech.
